nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Doxorubicin—muscle cancer	0.369	1	CrCtD
Valrubicin—urinary bladder cancer—muscle cancer	0.274	1	CtDrD
Valrubicin—Daunorubicin—Doxorubicin—muscle cancer	0.0783	0.333	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—muscle cancer	0.0783	0.333	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—muscle cancer	0.0783	0.333	CrCrCtD
Valrubicin—TOP2A—Etoposide—muscle cancer	0.0691	0.594	CbGbCtD
Valrubicin—TOP2A—Doxorubicin—muscle cancer	0.0471	0.405	CbGbCtD
Valrubicin—TOP2A—Vindesine—Vincristine—muscle cancer	0.000292	0.236	CbGdCrCtD
Valrubicin—TOP2A—Vinorelbine—Vincristine—muscle cancer	0.000184	0.149	CbGdCrCtD
Valrubicin—TOP2A—Podofilox—Etoposide—muscle cancer	0.000184	0.149	CbGdCrCtD
Valrubicin—TOP2A—Teniposide—Etoposide—muscle cancer	0.000184	0.149	CbGdCrCtD
Valrubicin—Anorectal discomfort—Etoposide—muscle cancer	0.000167	0.041	CcSEcCtD
Valrubicin—Rectal tenesmus—Doxorubicin—muscle cancer	0.000127	0.0312	CcSEcCtD
Valrubicin—TOP2A—Vinblastine—Vincristine—muscle cancer	0.000127	0.102	CbGdCrCtD
Valrubicin—Proctalgia—Doxorubicin—muscle cancer	0.000101	0.0248	CcSEcCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—muscle cancer	8.87e-05	0.0718	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—muscle cancer	8.87e-05	0.0718	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—muscle cancer	8.87e-05	0.0718	CbGdCrCtD
Valrubicin—Anorectal discomfort—Doxorubicin—muscle cancer	8.67e-05	0.0213	CcSEcCtD
Valrubicin—Local reaction—Doxorubicin—muscle cancer	8.56e-05	0.021	CcSEcCtD
Valrubicin—Pelvic pain—Doxorubicin—muscle cancer	7.79e-05	0.0191	CcSEcCtD
Valrubicin—Urinary retention—Vincristine—muscle cancer	7.78e-05	0.0191	CcSEcCtD
Valrubicin—Pneumonia—Dactinomycin—muscle cancer	7.1e-05	0.0174	CcSEcCtD
Valrubicin—Dysuria—Vincristine—muscle cancer	6.62e-05	0.0162	CcSEcCtD
Valrubicin—Pneumonia—Vincristine—muscle cancer	6.34e-05	0.0156	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—muscle cancer	5.85e-05	0.0144	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—muscle cancer	5.39e-05	0.0132	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—muscle cancer	5.39e-05	0.0132	CcSEcCtD
Valrubicin—Cystitis noninfective—Methotrexate—muscle cancer	5.34e-05	0.0131	CcSEcCtD
Valrubicin—Cystitis—Methotrexate—muscle cancer	5.28e-05	0.013	CcSEcCtD
Valrubicin—Pneumonia—Etoposide—muscle cancer	5.14e-05	0.0126	CcSEcCtD
Valrubicin—Ill-defined disorder—Dactinomycin—muscle cancer	5.12e-05	0.0126	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—muscle cancer	5.11e-05	0.0125	CcSEcCtD
Valrubicin—Anaemia—Dactinomycin—muscle cancer	5.1e-05	0.0125	CcSEcCtD
Valrubicin—Malaise—Dactinomycin—muscle cancer	4.98e-05	0.0122	CcSEcCtD
Valrubicin—Bladder pain—Methotrexate—muscle cancer	4.95e-05	0.0121	CcSEcCtD
Valrubicin—Back pain—Vincristine—muscle cancer	4.77e-05	0.0117	CcSEcCtD
Valrubicin—Myalgia—Dactinomycin—muscle cancer	4.7e-05	0.0115	CcSEcCtD
Valrubicin—Discomfort—Dactinomycin—muscle cancer	4.64e-05	0.0114	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—muscle cancer	4.63e-05	0.0114	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—muscle cancer	4.57e-05	0.0112	CcSEcCtD
Valrubicin—Anaemia—Vincristine—muscle cancer	4.56e-05	0.0112	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—muscle cancer	4.47e-05	0.011	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—muscle cancer	4.28e-05	0.0105	CcSEcCtD
Valrubicin—Myalgia—Vincristine—muscle cancer	4.2e-05	0.0103	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	4.1e-05	0.0101	CcSEcCtD
Valrubicin—Back pain—Etoposide—muscle cancer	3.86e-05	0.00948	CcSEcCtD
Valrubicin—Irritability—Methotrexate—muscle cancer	3.79e-05	0.0093	CcSEcCtD
Valrubicin—Feeling abnormal—Dactinomycin—muscle cancer	3.71e-05	0.00911	CcSEcCtD
Valrubicin—Ill-defined disorder—Etoposide—muscle cancer	3.71e-05	0.00909	CcSEcCtD
Valrubicin—Anaemia—Etoposide—muscle cancer	3.69e-05	0.00906	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dactinomycin—muscle cancer	3.68e-05	0.00904	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Vincristine—muscle cancer	3.67e-05	0.009	CcSEcCtD
Valrubicin—Malaise—Etoposide—muscle cancer	3.6e-05	0.00884	CcSEcCtD
Valrubicin—Abdominal pain—Dactinomycin—muscle cancer	3.56e-05	0.00874	CcSEcCtD
Valrubicin—Body temperature increased—Dactinomycin—muscle cancer	3.56e-05	0.00874	CcSEcCtD
Valrubicin—Chest pain—Etoposide—muscle cancer	3.4e-05	0.00834	CcSEcCtD
Valrubicin—Discomfort—Etoposide—muscle cancer	3.36e-05	0.00824	CcSEcCtD
Valrubicin—Gastrointestinal pain—Vincristine—muscle cancer	3.29e-05	0.00808	CcSEcCtD
Valrubicin—Asthenia—Dactinomycin—muscle cancer	3.23e-05	0.00793	CcSEcCtD
Valrubicin—Dysuria—Methotrexate—muscle cancer	3.21e-05	0.00788	CcSEcCtD
Valrubicin—Body temperature increased—Vincristine—muscle cancer	3.18e-05	0.00781	CcSEcCtD
Valrubicin—Abdominal pain—Vincristine—muscle cancer	3.18e-05	0.00781	CcSEcCtD
Valrubicin—Diarrhoea—Dactinomycin—muscle cancer	3.08e-05	0.00756	CcSEcCtD
Valrubicin—Pneumonia—Methotrexate—muscle cancer	3.08e-05	0.00756	CcSEcCtD
Valrubicin—Haematuria—Methotrexate—muscle cancer	2.92e-05	0.00716	CcSEcCtD
Valrubicin—Asthenia—Vincristine—muscle cancer	2.89e-05	0.00709	CcSEcCtD
Valrubicin—Vomiting—Dactinomycin—muscle cancer	2.86e-05	0.00703	CcSEcCtD
Valrubicin—Rash—Dactinomycin—muscle cancer	2.84e-05	0.00697	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—muscle cancer	2.78e-05	0.00682	CcSEcCtD
Valrubicin—Diarrhoea—Vincristine—muscle cancer	2.75e-05	0.00676	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—muscle cancer	2.75e-05	0.00674	CcSEcCtD
Valrubicin—Feeling abnormal—Etoposide—muscle cancer	2.69e-05	0.00659	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—muscle cancer	2.68e-05	0.00658	CcSEcCtD
Valrubicin—Nausea—Dactinomycin—muscle cancer	2.67e-05	0.00657	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—muscle cancer	2.67e-05	0.00654	CcSEcCtD
Valrubicin—Gastrointestinal pain—Etoposide—muscle cancer	2.66e-05	0.00654	CcSEcCtD
Valrubicin—Dizziness—Vincristine—muscle cancer	2.66e-05	0.00653	CcSEcCtD
Valrubicin—Abdominal pain—Etoposide—muscle cancer	2.58e-05	0.00632	CcSEcCtD
Valrubicin—Body temperature increased—Etoposide—muscle cancer	2.58e-05	0.00632	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—muscle cancer	2.58e-05	0.00632	CcSEcCtD
Valrubicin—Vomiting—Vincristine—muscle cancer	2.56e-05	0.00628	CcSEcCtD
Valrubicin—Rash—Vincristine—muscle cancer	2.54e-05	0.00623	CcSEcCtD
Valrubicin—Dermatitis—Vincristine—muscle cancer	2.53e-05	0.00622	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—muscle cancer	2.53e-05	0.0062	CcSEcCtD
Valrubicin—Headache—Vincristine—muscle cancer	2.52e-05	0.00619	CcSEcCtD
Valrubicin—Nausea—Vincristine—muscle cancer	2.39e-05	0.00587	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—muscle cancer	2.34e-05	0.00575	CcSEcCtD
Valrubicin—Asthenia—Etoposide—muscle cancer	2.34e-05	0.00574	CcSEcCtD
Valrubicin—Back pain—Methotrexate—muscle cancer	2.31e-05	0.00568	CcSEcCtD
Valrubicin—Pruritus—Etoposide—muscle cancer	2.31e-05	0.00566	CcSEcCtD
Valrubicin—Diarrhoea—Etoposide—muscle cancer	2.23e-05	0.00547	CcSEcCtD
Valrubicin—Ill-defined disorder—Methotrexate—muscle cancer	2.22e-05	0.00545	CcSEcCtD
Valrubicin—Anaemia—Methotrexate—muscle cancer	2.21e-05	0.00543	CcSEcCtD
Valrubicin—Malaise—Methotrexate—muscle cancer	2.16e-05	0.00529	CcSEcCtD
Valrubicin—Dizziness—Etoposide—muscle cancer	2.16e-05	0.00529	CcSEcCtD
Valrubicin—Vomiting—Etoposide—muscle cancer	2.07e-05	0.00509	CcSEcCtD
Valrubicin—Rash—Etoposide—muscle cancer	2.05e-05	0.00504	CcSEcCtD
Valrubicin—Dermatitis—Etoposide—muscle cancer	2.05e-05	0.00504	CcSEcCtD
Valrubicin—Headache—Etoposide—muscle cancer	2.04e-05	0.00501	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—muscle cancer	2.04e-05	0.00501	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—muscle cancer	2.04e-05	0.005	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—muscle cancer	2.04e-05	0.005	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—muscle cancer	2.01e-05	0.00494	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—muscle cancer	2e-05	0.00492	CcSEcCtD
Valrubicin—Nausea—Etoposide—muscle cancer	1.94e-05	0.00475	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—muscle cancer	1.92e-05	0.00472	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—muscle cancer	1.91e-05	0.0047	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—muscle cancer	1.87e-05	0.00458	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Methotrexate—muscle cancer	1.78e-05	0.00437	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—muscle cancer	1.76e-05	0.00433	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—muscle cancer	1.76e-05	0.00433	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—muscle cancer	1.74e-05	0.00428	CcSEcCtD
Valrubicin—Feeling abnormal—Methotrexate—muscle cancer	1.61e-05	0.00395	CcSEcCtD
Valrubicin—Gastrointestinal pain—Methotrexate—muscle cancer	1.6e-05	0.00392	CcSEcCtD
Valrubicin—Body temperature increased—Methotrexate—muscle cancer	1.54e-05	0.00379	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—muscle cancer	1.54e-05	0.00379	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	1.54e-05	0.00378	CcSEcCtD
Valrubicin—Asthenia—Methotrexate—muscle cancer	1.4e-05	0.00344	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—muscle cancer	1.39e-05	0.00342	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—muscle cancer	1.38e-05	0.00339	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—muscle cancer	1.38e-05	0.00339	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—muscle cancer	1.34e-05	0.00328	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—muscle cancer	1.34e-05	0.00328	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—muscle cancer	1.34e-05	0.00328	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—muscle cancer	1.29e-05	0.00317	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—muscle cancer	1.24e-05	0.00305	CcSEcCtD
Valrubicin—Rash—Methotrexate—muscle cancer	1.23e-05	0.00302	CcSEcCtD
Valrubicin—Dermatitis—Methotrexate—muscle cancer	1.23e-05	0.00302	CcSEcCtD
Valrubicin—Headache—Methotrexate—muscle cancer	1.22e-05	0.003	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—muscle cancer	1.21e-05	0.00298	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—muscle cancer	1.2e-05	0.00294	CcSEcCtD
Valrubicin—Nausea—Methotrexate—muscle cancer	1.16e-05	0.00285	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—muscle cancer	1.16e-05	0.00284	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—muscle cancer	1.12e-05	0.00274	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—muscle cancer	1.07e-05	0.00264	CcSEcCtD
Valrubicin—Rash—Doxorubicin—muscle cancer	1.07e-05	0.00262	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—muscle cancer	1.06e-05	0.00261	CcSEcCtD
Valrubicin—Headache—Doxorubicin—muscle cancer	1.06e-05	0.0026	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—muscle cancer	1e-05	0.00246	CcSEcCtD
